UnitedHealth Group (NYSE:UNH) had its target price hoisted by research analysts at Cantor Fitzgerald to $280.00 in a research note issued on Wednesday, January 17th. The brokerage presently has an “overweight” rating on the healthcare conglomerate’s stock. Cantor Fitzgerald’s price objective indicates a potential upside of 26.72% from the stock’s current price. Cantor Fitzgerald also issued estimates for UnitedHealth Group’s FY2018 earnings at $12.40 EPS and FY2019 earnings at $13.80 EPS.
Other analysts have also recently issued research reports about the company. Bank of America lifted their target price on UnitedHealth Group from $230.00 to $240.00 and gave the stock a “buy” rating in a research report on Wednesday, October 18th. Citigroup boosted their price target on UnitedHealth Group from $213.00 to $235.00 and gave the company a “buy” rating in a research report on Wednesday, October 18th. Leerink Swann restated a “buy” rating and issued a $240.00 price target (up previously from $225.00) on shares of UnitedHealth Group in a research report on Wednesday, October 18th. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 price target on the stock in a research report on Thursday, September 21st. Finally, Jefferies Group boosted their price target on UnitedHealth Group from $215.00 to $225.00 and gave the company a “buy” rating in a research report on Friday, October 13th. Two analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $243.22.
Shares of UnitedHealth Group (UNH) traded up $4.50 during midday trading on Wednesday, reaching $220.96. The company’s stock had a trading volume of 6,208,110 shares, compared to its average volume of 4,150,000. The stock has a market cap of $214,130.00, a P/E ratio of 20.63, a price-to-earnings-growth ratio of 1.29 and a beta of 0.70. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.73 and a quick ratio of 0.70. UnitedHealth Group has a 12 month low of $156.49 and a 12 month high of $250.79.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, topping the Zacks’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The business had revenue of $52.06 billion for the quarter, compared to analysts’ expectations of $51.57 billion. During the same quarter in the previous year, the firm earned $2.11 earnings per share. The business’s revenue was up 9.5% compared to the same quarter last year. equities analysts anticipate that UnitedHealth Group will post 12.51 earnings per share for the current year.
In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 198 shares of the stock in a transaction on Friday, January 19th. The stock was sold at an average price of $242.55, for a total transaction of $48,024.90. Following the transaction, the director now owns 1,790,567 shares of the company’s stock, valued at approximately $434,302,025.85. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Michele J. Hooper sold 10,000 shares of the stock in a transaction on Wednesday, January 31st. The stock was sold at an average price of $237.76, for a total value of $2,377,600.00. Following the transaction, the director now directly owns 37,284 shares in the company, valued at approximately $8,864,643.84. The disclosure for this sale can be found here. In the last ninety days, insiders sold 53,853 shares of company stock worth $12,358,508. 0.89% of the stock is owned by corporate insiders.
Several institutional investors have recently modified their holdings of the business. Alexandria Capital LLC increased its holdings in shares of UnitedHealth Group by 5,310.4% during the 4th quarter. Alexandria Capital LLC now owns 12,498 shares of the healthcare conglomerate’s stock worth $2,755,000 after buying an additional 12,267 shares during the last quarter. Sequoia Wealth Management LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth $222,000. Timber Hill LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth $2,325,000. GM Advisory Group Inc. increased its holdings in shares of UnitedHealth Group by 80.5% during the 4th quarter. GM Advisory Group Inc. now owns 3,451 shares of the healthcare conglomerate’s stock worth $761,000 after buying an additional 1,539 shares during the last quarter. Finally, Baird Financial Group Inc. increased its holdings in shares of UnitedHealth Group by 0.4% during the 4th quarter. Baird Financial Group Inc. now owns 227,200 shares of the healthcare conglomerate’s stock worth $50,089,000 after buying an additional 970 shares during the last quarter. 86.24% of the stock is currently owned by institutional investors.
TRADEMARK VIOLATION WARNING: “UnitedHealth Group (UNH) Price Target Increased to $280.00 by Analysts at Cantor Fitzgerald” was originally posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this piece on another domain, it was stolen and republished in violation of United States and international copyright laws. The correct version of this piece can be viewed at https://ledgergazette.com/2018/02/12/unitedhealth-group-unh-price-target-raised-to-280-00.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.